ROCKWELL MEDICAL, INC.

For the period ended Nov 12, 2025. Filed Nov 12, 2025.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 12, 2025 · Filed Nov 12, 2025

Use the contents to explore the available documents and sections.

RMTI$7.73+1.7%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

EX-99.1 · Adjusted EBITDA

Adjusted EBITDA

Adjusted EBITDA for the three months ended September 30, 2025 was $50,000 compared to Adjusted EBITDA of $2.8 million for the third quarter of 2024. Adjusted EBITDA in the third quarter of 2025 represents a slight improvement over Adjusted EBITDA of ($0.2) million in the second quarter of 2025.

Adjusted EBITDA for the nine months ended September 30, 2025 was ($0.6) million compared with Adjusted EBITDA of $3.7 million for the same period in 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.